Overview
- 47 inspections across 44 sites are on record.
- 90 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-12.
At a glance
Inspections
47
Sites
44
Observations
90
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 12 Jun 2026 | Human Drugs | On file |
| Richmond VA Medical Center | 12 May 2026 | Human Drugs | View 483 → |
| Gillson Testing, Inc. | 15 Apr 2026 | Human Drugs | |
| Bora Pharmaceuticals Injectables Inc | 20 Mar 2026 | Human Drugs | View 483 → |
| Phibro Animal Health Corporation | 15 Jan 2026 | Animal Drugs & Feeds |
Sites inspected
Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)Jinan, China1 insp.
Richmond VA Medical CenterRichmond, United States1 insp.
Gillson Testing, Inc.Schnecksville, United States1 insp.
Bora Pharmaceuticals Injectables IncBaltimore, United States1 insp.
Phibro Animal Health CorporationWillow Island, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sena G Dissmeyer5 shared
Kara J Wright3 shared
Yaharn Su3 shared
Bijoy Panicker3 shared
Ephrem T Hunde3 shared
Amy N Chen3 shared
Azeezat M Lawal2 shared
Johnny D Nwankwo2 shared
Rachael O Oyewole2 shared
Jeremy T Dautrich1 shared
Full investigator report
Get the verbatim findings behind Tekalign Wondimu's 90 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site